drugset / Trial / NCT07068607

Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial

NCT07068607

Phase 4 Recruiting 400 enrolled Yongquan Shi
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to evaluate the efficacy of vonoprazan combined with different antibiotics in dual therapy for Helicobacter pylori eradication treatment. Newly infected patients were randomly assigned to four groups: amoxicillin dual therapy, tetracycline dual therapy, minocycline dual therapy, and bismuth quadruple therapy. At the follow - up visit in the 6th week, urea breath test, rapid urease test, or Helicobacter pylori fecal antigen test will be conducted to confirm eradication.

Timeline

Start
2025-04-01
Primary completion
2025-10-01
Completion
2025-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1000 mg Oral
Comparator Bismuth Potassium Citrate Unknown 220 mg
Comparator Clarithromycin Small molecule 500 mg
Subject Minocycline Small molecule 100 mg Oral
Subject Tetracycline Unknown 500 mg Oral
Subject Vonoprazan Other / unclassified 20 mg